With the emergence and long-term Impact of COVID-19, the Global Progesterone Market to reach USD 3147.77 Million by 2030
Bizwit Research & Consulting LLP’s Recent Analysis on Global Progesterone Market is poised to raised USD 3147.77 Million by 2030. Progesterone is a female hormone that is primarily produced by the ovaries after ovulation. It plays a crucial role in preparing the uterus for pregnancy and maintaining a healthy pregnancy. Progesterone also helps regulate the menstrual cycle and is involved in development of breast tissue. It can also be used as a medication to treat various conditions, such as irregular periods, infertility, and menopausal symptoms. It is often prescribed as part of hormone replacement therapy for menopausal women. The Progesterone market is expanding because of increasing incidence of endometrial cancer and growing cases of female infertility and breast cancer.
During pregnancy, progesterone levels rise significantly and help to prevent premature contractions of the uterus. After menopause, progesterone production declines, along with estrogen, which can lead to symptoms such as hot flashes, vaginal dryness, and bone loss. Its prevalence has progressively increased during the last few decades. According to the American Cancer Society, in 2023 about 66,200 new cases of cancer of the body of the uterus will be diagnosed. Furthermore, around 13,030 women will die from cancers of the uterine body in the United States. In addition, about 13,960 new cases of invasive cervical cancer will be diagnosed and 4,310 women will die from cervical cancer during the same year.
Another important component driving space is increasing cases of female infertility and breast cancer. According to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. In addition, as per the American Society of Clinical Oncology in 2023, an estimated 297,790 women in the United States will be diagnosed with invasive breast cancer, and 55,720 women will be diagnosed with non-invasive breast cancer. Also, advancements in formulation and technological advancements in the medical industry would create a lucrative growth prospectus for the market over the forecast period. However, lack of awareness regarding the availability of hormone therapy stifles market growth throughout the forecast period of 2023-2030.
The regional analysis of the global Progesterone Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America dominated the market in 2022 owing to the increasing number of breast cancer in the region. According to Breastcancer.org, In 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive breast cancer. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising target populations, and active participation of government and nonprofit organizations in the market space.
The Global Progesterone Market is highly competitive owing to the presence of several key manufacturers such as Estrellas Life Sciences Private Ltd, Bionpharma Inc.,, Sofgen Pharmaceuticals,, Teva Pharmaceuticals Industries Ltd, Virtus Pharmaceuticals Llc,, Blubell Pharma Group Company, Aquatic Remedies Pvt. Ltd.,, Intas Pharmaceuticals Ltd.,,Shanghai Yijing Industrial Co ltd, Wuhan Honor Bio-Pharm Co., Ltd.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Global Progesterone Market Size study & Forecast, by Type (Natural Progesterone, Synthetic Progesterone), By Mode of Delivery (Injectable, Suspended Form, Oral), By Application (Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions) and Regional Analysis, 2023-2030
Key findings of the study suggest:
- Global Progesterone Market is anticipated to grow with a healthy growth rate of more than 13.3% over the forecast period 2023-2030
- In the Application segment, Natural Progesterone emerged as the leading market segment in 2022.
- North America dominated the market in 2022 owing to the increasing number of breast cancer in the region.
- Asia-Pacific is expected at a high CAGR followed by North America during 2023-2030
Bizwit Research & Consulting has considered the following segments for the study:
- Natural Progesterone
- Synthetic Progesterone
By Mode of Delivery:
- Suspended Form
- Regulation of the Menstrual Cycle
- Dysfunctional Uterine Bleeding
- Endometrial Cancer
- Hyperplastic Precursor Lesions
- North America
- Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: firstname.lastname@example.org
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Global Business Development
Phone : +1 209 498-3066